Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses.
about
Safety of engineered allergen-specific immunotherapy vaccinesCarrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactionsCell response in rabbits infected with T. pallidum as measured by the leucocyte migration inhibition test.Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccinationA nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.Cross-reactivity of IgE antibodies to allergens.Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy.Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.Immunologic memory cells of bone marrow origin. Increased burst size of specific immunocyte precursors.Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "nonimmunogenic" hapten-polypeptide conjugates.The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response.Receptors on immunocompetent cells. 3. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding cells of immunized guinea pigsReceptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs.Antigenic promotion. Increase in hapten-specific plaque-forming cells after pre-injection with structurally unrelated macromolecules.Induction of immunity and tolerance in vitro by hapten protein conjugates. I. The relationship between the degree of hapten conjugation and the immunogenicity of dinitrophenylated polymerized flagellinImmunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin).Hapten-specific tolerance. Preferential depression of the high affinity antibody response.Induction of immunity and tolerance in vitro by hapten protein conjugates. 3. Hapten inhibition studies of antigen binding to B cells in immunity and toleranceSurface antigens of immunocompetent cells. 3. In vitro studies of the role of B and T cells in immunological memory.Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factorRegulation of the immune response. II. Qualitative and quantitative differences between thymus- and bone marrow-derived lymphocytes in the recognition of antigen.Immunodeviation by passive antibody, an expression of selective immunodepression. II. Action of guinea pig IgG1 and IgG2 anticarrier antibodies.Bystander help in primary immune responses in vivo.Epitope-specific regulation and the literature.Radioresistance of the enhancing effect of cells from carrier-immunized mice in an in vitro primary immune response.Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy.The mechanism of tolerance induction in thymus-derived lymphocytes; I. intracellular inactivation of hapten-reactive helper T lymphocytes by hapten-nonimmunogenic copolymer of D-amino acids.Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour.Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.Antibody response of hamsters to A2-Hong Kong virus vaccine after priming by heterotypic virus infection.Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. II. Increased levels of IgG antibodies to foods in children who subsequently develop IgE antibodies to inhalant allergens.Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Ia- and Ia+ helper T cells.Passive antibody and the immune response. Factors which determine enhancement and suppression.Surface antigens of immunocompetent cells. I. Effect of theta and PC.1 alloantisera on the ability of spleen cells to transfer immune responsesRejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.Dual regulatory role of the thymus in the maturation of immune response in the rabbitImmune responses against native and chemically modified albumins in mice. I. Analysis of non-thymus-processed (B) and thymus-processed (T) cell responses against methylated bovine serum albumin.Anergy and suppression in B-cell responses.The immune response against hapten-autologous protein conjugates in the mouse. II. Carrier specificity in the secondary anti-hapten response and evidence of the existence of specific helper cells.
P2860
Q26860962-46319E37-28FF-4D17-BD85-8FB443AE9046Q28362747-40D0FD16-FC39-4EDB-8644-D9FC6763AB97Q33661120-7BA967BE-A427-40E3-9FBB-EF054617BC53Q33883053-CCC29134-AE72-4726-8EEC-D9251F494966Q34106036-A3B04AAB-A09E-4AC4-98D6-56AE27817266Q34291170-BB620405-9460-4DE3-A246-F7E1FBB9B998Q34430399-6E6E3DAB-7E2C-4886-B1A5-45C827A53B25Q36125684-27785C1B-3B86-41CD-80CA-58757C437446Q36270975-D9389E45-1F8E-4BB4-9227-7273F4733011Q36271140-9BA5FE06-F1E5-4492-A8B3-EEFFD3C50C3DQ36271186-DB56427E-1578-4900-8F43-0969712EF2D7Q36271198-4CD8178B-90F6-41D8-A094-BDC6BAB09B31Q36271226-49967A50-92BF-4B81-B673-2219ABD67B2BQ36271282-C0003FB6-69DC-4D81-BA26-6DCB83EEB34EQ36271503-77896227-6F46-4BEE-8CC4-5A7C1938BCD7Q36271879-CB362029-FD0A-4E04-837C-D15F14A1A573Q36271889-146A8A81-856D-4356-B764-7E8FB389D32EQ36271902-A72E08FD-88E5-4DF2-9EB5-9DE2F32CB4E8Q36271969-99BAFC15-88BD-426E-A63D-D424C3046025Q36272162-4AE23AB3-9916-4721-BBD2-CEFFA07BFCF2Q36272365-3D366DCE-9719-4633-ACB6-226340308FAFQ36272810-13C833A6-6FAC-4CD9-9043-035EEC87B28CQ36352880-78F7EB00-AA4E-4C07-A011-845DCBF2F297Q36592850-539534EA-413E-4C08-8A45-FFC1BF26772DQ37472585-0535387A-B9F8-49DA-ACEE-F7F83BA0F937Q37660270-2A570154-4F8E-42ED-BF66-CEC6B3FD45B5Q39323629-38DD8271-6EB5-4ABD-8BEB-6985C3B1ACBCQ39341538-BDF564B5-E416-4493-AE7B-D70A8A3E387AQ40373874-CB47DD4E-5B95-4584-8CB1-31899256E486Q40915093-C2B43D29-5597-4BEC-B3DC-E4851E4BC61CQ41183142-71698C80-5364-4239-AEC5-DE2DF15D98CBQ41367783-04EC094E-69F9-4376-9BAE-8EC6516F037CQ41509342-301A1B66-F693-4EC3-97E2-1301C4D75F8DQ41902902-AEBF069C-B4C5-4058-A033-028116519EC5Q42012267-AC2E3404-B7F5-4332-B62C-936CB9BA2C5FQ42016513-CB727197-D152-4388-838D-7CB335B005C4Q42119398-83FD1289-0A9E-4BE6-A51B-EFFF317E3308Q52069121-A038E76A-9F59-4543-B963-C96E96847945Q52255247-E6F76856-C8C6-4B12-A535-EBC0FC8AC8A3
P2860
Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Carrier function in anti-hapte ...... nti-hapten antibody responses.
@ast
Carrier function in anti-hapte ...... nti-hapten antibody responses.
@en
type
label
Carrier function in anti-hapte ...... nti-hapten antibody responses.
@ast
Carrier function in anti-hapte ...... nti-hapten antibody responses.
@en
prefLabel
Carrier function in anti-hapte ...... nti-hapten antibody responses.
@ast
Carrier function in anti-hapte ...... nti-hapten antibody responses.
@en
P2093
P2860
P356
P1476
Carrier function in anti-hapte ...... nti-hapten antibody responses.
@en
P2093
P2860
P304
P356
10.1084/JEM.132.2.283
P407
P577
1970-08-01T00:00:00Z